Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.
3.
5.

Improving cost-effectiveness of hypertension management at a community health centre.

Edwards PR, Lunt DW, Fehrsen GS, Lombard CJ, Steyn K.

S Afr Med J. 1998 May;88(5):549-54.

PMID:
9638122
6.
7.

Economic analysis of a randomized trial of academic detailing interventions to improve use of antihypertensive medications.

Simon SR, Rodriguez HP, Majumdar SR, Kleinman K, Warner C, Salem-Schatz S, Miroshnik I, Soumerai SB, Prosser LA.

J Clin Hypertens (Greenwich). 2007 Jan;9(1):15-20.

8.

[Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].

Fender P, Guilhot J, Tilly B, Salanave B, Allemand H.

Therapie. 2001 Mar-Apr;56(2):111-8. French.

PMID:
11471361
10.

Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.

Iyengar RN, Balagere DS, Henderson RR, LeFrancois AL, Rabbitt RM, Frazee SG.

J Manag Care Spec Pharm. 2014 Aug;20(8):851-61.

11.

Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad.

Tomas A, Tomić Z, Milijasević B, Ban M, Horvat O, Vukmirović S, Sabo A.

Vojnosanit Pregl. 2016 Jun;73(6):531-7.

PMID:
27498444
12.

Antihypertensive drug prescribing in Grampian.

Ross S, Macleod MJ.

Br J Clin Pharmacol. 2005 Sep;60(3):300-5.

13.

Antihypertensive drug prescription trends at the primary health care centres in Bahrain.

Jassim al Khaja KA, Sequeira RP, Wahab AW, Mathur VS.

Pharmacoepidemiol Drug Saf. 2001 May;10(3):219-27.

PMID:
11501335
16.

Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort study.

Heinze G, Hronsky M, Reichardt B, Baumgärtel C, Müllner M, Bucsics A, Winkelmayer WC.

Appl Health Econ Health Policy. 2015 Apr;13(2):193-205. doi: 10.1007/s40258-014-0143-4.

PMID:
25536928
18.
19.

Eligibility to treatment and economic effect of the implementation of the new U.S. or European Society of Hypertension/European Society of Cardiology hypertension guidelines.

Marques-Vidal P, Waeber G, Waeber B, Vollenweider P.

J Hypertens. 2015 Apr;33(4):868-73. doi: 10.1097/HJH.0000000000000466.

PMID:
25915892
20.

Supplemental Content

Support Center